60 DEGREES PHARMACEUTICALS, INC. (SXTP)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Product revenues net of discounts and rebates | 100,932 | 163,552 | 135,293 | 124,972 |
| Cost of revenues | 50,051 | 73,272 | 111,687 | 89,564 |
| Gross profit | 50,881 | 90,280 | 23,606 | 35,408 |
| Research revenues | 206,939 | 92,731 | 12,818 | 728 |
| Net revenue | 257,820 | 183,011 | 36,424 | - |
| Research and development | 249,884 | 407,622 | 940,063 | 3,095,326 |
| General and administrative expenses | 1,612,764 | 1,686,264 | 1,215,053 | 1,129,560 |
| Total operating expenses | 1,862,648 | 2,093,886 | 2,155,116 | 4,224,886 |
| Income (loss) from continuing operations, net of tax, attributable to parent | - | - | - | 36,136 |
| Loss from operations | -1,604,828 | -1,910,875 | -2,118,692 | -4,188,750 |
| Other operating income (expense), net | - | - | 16,623 | 19,684 |
| Interest expense, other | - | - | 1,467 | 3,621 |
| Gain (loss) on sale of derivatives | - | - | -56,712 | -1,101 |
| Other income, net | 13,066 | 30,322 | - | - |
| Interest expense | 1,221 | 1,790 | - | - |
| Change in fair value of derivative liabilities | 140,447 | -5,105 | - | - |
| Total interest and other (expense) income, net | -128,602 | 33,637 | -41,556 | - |
| Interest income (expense), operating | - | - | - | 14,962 |
| Loss from operations before provision for income taxes | -1,733,430 | -1,877,238 | -2,160,248 | -4,173,788 |
| Provision for income taxes (note 9) | 1,500 | 63 | 250 | 438 |
| Net loss | -1,734,930 | -1,877,301 | -2,160,498 | -4,174,226 |
| Net loss noncontrolling interest | -1,204 | -752 | -713 | -1,471 |
| Net loss attributed to 60 degrees pharmaceuticals, inc | -1,733,726 | -2,004,611 | -2,271,953 | -4,287,499 |
| Cumulative dividends on series a preferred stock | - | 118,158 | 116,571 | 117,881 |
| Unrealized foreign currency translation loss | - | -9,904 | 4,403 | 3,137 |
| Net (loss) income - attributed to common stockholders | - | -2,004,611 | -2,271,953 | -4,287,499 |
| Basic (in dollars per share) | -1.25 | -1.56 | -0.93 | -4.23 |
| Basic (in shares) | 1,472,891 | 1,283,462 | 2,443,198 | 1,014,779 |
| Diluted (in dollars per share) | -1.25 | -1.56 | -0.93 | -4.23 |
| Diluted (in shares) | 1,472,891 | 1,283,462 | 2,443,198 | 1,014,779 |